Model for End Stage Liver Disease (MELD) scores are used to determine priority on the liver transplant wait list in the United States. In this video, George A. Makar, MD, MSCE, discusses the MELD scores in the context of controversy, best practice and current guidelines. Dr. Makar is the Medical Director for Liver Transplantation at the Penn Transplant Institute.

Related Links

• Clinical Briefing: Living Donor Liver Transplantation at Penn Medicine
• Case Study: A 28-year-old woman with cirrhosis secondary to biliary atresia, bleeding esophageal varices, hepatic encephalopathy, and ascites is referred to the Penn Liver Transplant team.
• Dr. Makar’s Profile